Pfizer Inc shares rose today following yesterday’s announcement that BIND Therapeutics is to extend its global Collaboration with the pharmaceuticals company. This joint move will entail the development and commercialisation for multiple Accurins. The Partnership was originally formed in April 2013, and the first program was due to end in September 2015, but both companies have agreed to the extension for the second program until March 2016. Furthermore, data showed that America’s largest drugs company showed that they spent $4.54 billion more on consumer advertisements indicating that Pfizers finances and brand are strong. Pfizer shares are currently trading 0.33% higher at $34.46.
Stock News April 7th 2015
Pfizer Inc shares rose today following yesterday’s announcement that BIND Therapeutics is to extend its global Collaboration with the pharmaceuticals company. This joint move will entail the development and commercialisation for multiple Accurins. The Partnership was originally formed in April 2013, and the first program was due to end in September 2015, but both companies have agreed to the extension for the second program until March 2016. Furthermore, data showed that America’s largest drugs company showed that they spent $4.54 billion more on consumer advertisements indicating that Pfizers finances and brand are strong. Pfizer shares are currently trading 0.33% higher at $34.46.
Related Posts: